In patients with obesity with T2DM, glucagon-like peptide-1 receptor agonists (GLP-1 RA), like semaglutide and dulaglutide, help control hyperglycemia and reduce weight. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.